Actives from the Micro-Immunotherapy Medicine 2LMIREG® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function

• DOI: 10.2147/jir.s445053
• Publication Date: 2024-02-21T04:10:11Z
• Authors: Camille Jacques; Flora Marchand; Mathias Chatelais; Ilaria Floris
• Keywords: Proinflammatory cytokine; Mitochondrial ROS

Micro-immunotherapy (MI) is a therapeutic option employing low doses (LD) and ultra-low (ULD) of cytokines immune factors to help the organism at modulating responses. In an overpowering inflammatory context, this strategy may support restoration body's homeostasis, as active ingredients MI medicines' (MIM) could boost or slow down physiological functions cells. The aim study evaluate for first time in vitro anti-inflammatory properties some actives employed by MIM interest several human cell models.